Homocystinemia as an Independent Risk Factor in the Chinese Population at a High Risk of Coronary Artery Disease

American Journal of Cardiology

Volumn 100, Issue 3, 2007, Pages 455-458

  Ni, Mei ^a   Zhang, Xing Hua ^b   Jiang, Shi Liang ^b   Zhang, Yun ^a  

^a BEIJING HOSPITAL   (China)

^b SHANDONG PROVINCIAL HOSPITAL AFFILIATED TO SHANDONG UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIHYPERTENSIVE AGENT; C REACTIVE PROTEIN; CHOLESTEROL; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HOMOCYSTEINE; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADULT; AGING; ANGIOCARDIOGRAPHY; ARTICLE; CARDIOVASCULAR RISK; CHINESE; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DIABETES MELLITUS; DIASTOLIC BLOOD PRESSURE; DYSLIPIDEMIA; FAMILY HISTORY; FEMALE; GENDER; HIGH RISK POPULATION; HOMOCYSTINURIA; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; OBESITY; POPULATION RESEARCH; PRIORITY JOURNAL; SMOKING; SYSTOLIC BLOOD PRESSURE; BLOOD; CHINA; CORONARY ARTERY ATHEROSCLEROSIS; HYPERHOMOCYSTEINEMIA; MIDDLE AGED; RISK FACTOR;

CHINA; CORONARY ARTERIOSCLEROSIS; FEMALE; HOMOCYSTEINE; HUMANS; HYPERHOMOCYSTEINEMIA; MALE; MIDDLE AGED; RISK FACTORS;

EID: 34447649753     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjcard.2007.03.046     Document Type: Article

References (15)

1. Lonn E., Yusuf S., Arnold M.J., Sheridan P., Pogue J., Micks M., McQueen M.J., Probstfield J., Fodor G., Held C., Genest Jr. J., and Heart Outcomes Prevention Evaluation (HOPE) 2 Investigators. Homocysteine lowering with folic acid and B vitamins in vascular disease. N Engl J Med 354 (2006) 1567-1577
2. Bonaa K.H., Njolstad I., Ueland P.M., Schirmer H., Tverdal A., Steigen T., Wang H., Nordrehaug J.E., Arnesen E., Rasmussen K., and NORVIT Trial Investigators. Homocysteine lowering and cardiovascular events after acute myocardial infarction. N Engl J Med 354 (2006) 1578-1588
3. National Institutes of Health. Clinical guidelines on the identification, evaluation, and treatment of overweight and obesity in adults-the evidence report. Obes Res 6 suppl 2 (1998) 51S-209S
4. 1999 World Health Organization-International Society of Hypertension guidelines for the management of hypertension: guidelines subcommittee. J Hypertens 17 (1999) 151-183
5. National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). Third report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report. Circulation 106 (2002) 3143-3421
6. Araki A., and Sako Y. Determination of free and total homocysteine in human plasma by high-performance liquid chromatography with fluorescence detection. J Chromatogr 422 (1987) 43-52
7. Bostom A.G., and Selhub J. Homocysteine and arteriosclerosis: subclinical and clinical disease associations. Circulation 99 (1999) 2361-2363
8. van Guldener C., Nanayakkara P.W., and Stehouwer C.D. Homocysteine and blood pressure. Curr Hypertens Rep 5 (2003) 26-31
9. Lim U., and Cassano P.A. Homocysteine and blood pressure in the Third National Health and Nutrition Examination Survey, 1988-1994. Am J Epidemiol 156 (2002) 1105-1113
10. van Dijk R.A., Rauwerda J.A., Steyn M., Twisk J.W., and Stehouwer C.D. Long-term homocysteine-lowering treatment with folic acid plus pyridoxine is associated with decreased blood pressure but not with improved brachial artery endothelium-dependent vasodilation or carotid artery stiffness: a 2-year, randomized, placebo-controlled trial. Arterioscler Thromb Vasc Biol 21 (2001) 2072-2079
11. Tayama J., Munakata M., Yoshinaga K., and Toyota T. Higher plasma homocysteine concentration is associated with more advanced systemic arterial stiffness and greater blood pressure response to stress in hypertensive patients. Hypertens Res 29 (2006) 403-409
12. Jacques P.F., Bostom A.G., Wilson P.W., Rich S., Rosenberg I.H., and Selhub J. Determinants of plasma total homocysteine concentration in the Framingham Offspring cohort. Am J Clin Nutr 73 (2001) 613-621
13. Russo G.T., Friso S., Jacques P.F., Rogers G., Cucinotta D., Wilson P.W., Ordovas J.M., Rosenberg I.H., Selhub J., and Framingham Offspring Study Cohort. Age and gender affect the relation between methylenetetrahydrofolate reductase C677T genotype and fasting plasma homocysteine concentrations in the Framingham Offspring Study Cohort. J Nutr 133 (2003) 3416-3421
14. Ho C.H. The influence of age, sex, vitamin B(12), folate levels and methylenetetrahydrofolate reductase C677T genetic mutations on plasma homocysteine in the Chinese population. Haematologica 85 (2000) 1051-1054
15. Gao X., Yao M., McCrory M.A., Ma G., Li Y., Roberts S.B., and Tucker K.L. Dietary pattern is associated with homocysteine and B vitamin status in an urban Chinese population. J Nutr 133 (2003) 3636-3642